ENDRA Life Sciences (NDRA) Other Non Operating Income (2016 - 2025)
ENDRA Life Sciences (NDRA) posted quarterly Other Non Operating Income of $42018.0 for Q3 2025, down 98.63% YoY from $3.1 million in Q3 2024, and up 221.58% sequentially from $13066.0 in Q2 2025.
ENDRA Life Sciences (NDRA) Other Non Operating Income (2016 - 2025) Analysis & Trends
ENDRA Life Sciences has disclosed Other Non Operating Income across 10 years of filings, most recently posting $42018.0 for Q3 2025.
- In Q3 2025, Other Non Operating Income fell 98.63% year-over-year to $42018.0; the TTM figure through Sep 2025 stood at $3.1 million (down 22.91% YoY), while the FY2024 annual figure was $3.1 million, up 568.14% from the prior year.
- Other Non Operating Income improved to $42018.0 in Q3 2025, from $13066.0 in the prior quarter.
- Over the last five years, Other Non Operating Income for NDRA reached as high as $3.1 million in Q3 2024 and fell as low as -$350145.0 in Q4 2021.
- The 5-year median for Other Non Operating Income is $18425.5 (2022), against an average of $466095.5.
- The widest YoY moves for Other Non Operating Income: up 10980.93% in 2024, down 99.61% in 2024.
- A 5-year view of Other Non Operating Income shows it stood at -$350145.0 in 2021, then jumped by 106.79% to $23785.0 in 2022, then jumped by 3779.45% to $922726.0 in 2023, then surged by 225.62% to $3.0 million in 2024, then plunged by 98.6% to $42018.0 in 2025.
- According to Business Quant data, Other Non Operating Income over the past three periods registered $42018.0, $13066.0, and $24390.0 for Q3 2025, Q2 2025, and Q1 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn |
| 10 | ENDRA Life Sciences | 5.95 Mn | 5.59 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 42,018.00 |
| Jun 30, 2025 | 13,066.00 |
| Mar 31, 2025 | 24,390.00 |
| Dec 31, 2024 | 3.00 Mn |
| Sep 30, 2024 | 3.07 Mn |
| Jun 30, 2024 | 1,700.00 |
| Mar 31, 2024 | 4,841.00 |
| Dec 31, 2023 | 922,726.00 |
| Sep 30, 2023 | -28,226.00 |
| Jun 30, 2023 | 437,433.00 |
| Mar 31, 2023 | 3,418.00 |
| Dec 31, 2022 | 23,785.00 |
| Sep 30, 2022 | -23,011.00 |
| Dec 31, 2021 | -350,145.00 |
| Jun 30, 2021 | 1,086.00 |
| Mar 31, 2021 | 308,600.00 |
| Jun 30, 2020 | 1,265.00 |
| Mar 31, 2020 | 6,617.00 |
| Dec 31, 2019 | -51,575.00 |
| Sep 30, 2019 | -44,612.00 |